Coordinated control of senescence by lncRNA and a novel T-box3 co-repressor complex
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Cellular senescence is a crucial tumor suppressor mechanism. We discovered a CAPERα/TBX3 repressor complex required to prevent senescence in primary cells and mouse embryos. Critical, previously unknown roles for CAPERα in controlling cell proliferation are manifest in an obligatory interaction with TBX3 to regulate chromatin structure and repress transcription of CDKN2A-p16INK and the RB pathway. The IncRNA UCA1 is a direct target of CAPERα/TBX3 repression whose overexpression is sufficient to induce senescence. In proliferating cells, we found that hnRNPA1 binds and destabilizes CDKN2A-p16INK mRNA whereas during senescence, UCA1 sequesters hnRNPA1 and thus stabilizes CDKN2A-p16INK. Thus CAPERα/TBX3 and UCA1 constitute a coordinated, reinforcing mechanism to regulate both CDKN2A-p16INK transcription and mRNA stability. Dissociation of the CAPERα/TBX3 co-repressor during oncogenic stress activates UCA1, revealing a novel mechanism for oncogene-induced senescence. Our elucidation of CAPERα and UCA1 functions in vivo provides new insights into senescence induction, and the oncogenic and developmental properties of TBX3.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 4×
“We compared CAPERα/TBX3 co-regulated transcripts to a published data set comparing PS and G12VRAS fibroblasts (Loayza-Puch et al., 2013).”
BackgroundInfluentialLong non-coding RNAs: new players in cell differentiation and development
Fatica, A., & Bozzoni, I. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3606 · Cited by 2,980
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278 · cited 2×
“The p16/retinoblastoma protein (RB) and p53 tumor suppressor pathways are key regulators of senescence induction and maintenance in many cell types (Narita et al., 2003). p14ARF-p53 activates p21, whereas the p16INK4a-RB pathway culminates in E2F transcriptional target repression and senescence…”
BackgroundThe essence of senescence: Figure 1.
Kuilman, T., Michaloglou, C., Mooi, W. J., & Peeper, D. S. (2010) · Genes & Development · doi:10.1101/gad.1971610 · Cited by 2,038
Suppression of induced pluripotent stem cell generation by the p53–p21 pathway
Hong, H., Takahashi, K., Ichisaka, T., Aoi, T., Kanagawa, O., Nakagawa, M., Okita, K., & Yamanaka, S. (2009) · Nature · doi:10.1038/nature08235 · Cited by 1,301 · cited 2×
“Efficacy and specificity of the pRb, p53, and p16 shRNAs was validated with second shRNAs, and these reagents have been used extensively by many investigators in the years since their initial publication (Masutomi et al., 2003; Stewart et al., 2003; Boehm et al., 2005; Haga et al., 2007; Hong et al., 2009; Elzi et al.…”
BackgroundSharova, L. V., Sharov, A. A., Nedorezov, T., Piao, Y., Shaik, N., & Ko, M. S. H. (2009) · DNA Research · doi:10.1093/dnares/dsn030 · Cited by 591 · cited 7×
“The results we obtained were also similar to those reported for MYC mRNA (Herrick and Ross, 1994; Sharova et al., 2009), CDKN1A mRNA in HT29-tsp53 cells (Melanson et al.”
BackgroundResultInfluentialMutations in human TBX3 alter limb, apocrine and genital development in ulnar-mammary syndrome
Bamshad, M., Lin, R. C., Law, D. J., Watkins, W. S., Krakowiak, P. A., Moore, M. E., Franceschini, P., Lala, R., Holmes, L. B., Gebuhr, T. C., et al. (1997) · Nature Genetics · doi:10.1038/ng0797-311 · Cited by 540 · cited 3×
“Previous studies showed that TBX3 represses transcription of p14ARF (upstream of p53) (Bamshad et al., 1997; Fan et al., 2009; Kumar et al., 2014), yet embryonic lethality and mammary phenotypes of Tbx3 mutants are p53-independent (Jerome-Majewska et al., 2005).”
BackgroundCoppé, J.-P., Rodier, F., Patil, C. K., Freund, A., Desprez, P.-Y., & Campisi, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.257071 · Cited by 506
p53-dependent release of Alarmin HMGB1 is a central mediator of senescent phenotypes
Davalos, A. R., Kawahara, M., Malhotra, G. K., Schaum, N., Huang, J., Ved, U., Beausejour, C. M., Coppe, J.-P., Rodier, F., & Campisi, J. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201206006 · Cited by 439 · cited 2×
“…CAPERα/TBX3 targets, as the complex roles of these pathways in the senescence associated secretory phenotype, inducing or enforcing autocrine and paracrine senescence, and tumor progression are emerging (Hubackova et al., 2010; Senturk et al., 2010; Hubackova et al., 2012; Davalos et al., 2013).”
BackgroundJacobs, J. J. L., Keblusek, P., Robanus-Maandag, E., Kristel, P., Lingbeek, M., Nederlof, P. M., van Welsem, T., van de Vijver, M. J., Koh, E. Y., Daley, G. Q., et al. (2000) · Nature Genetics · doi:10.1038/81583 · Cited by 368 · cited 4×
“As noted above, expression of CDKN2A-p14ARF and CDKN1A-p21CIP are repressed by TBX2 and TBX3 and this is postulated to confer the ability of overexpressed TBX2 and TBX3 to permit senescence bypass of Bmi1−/− and SV40 transformed mouse embryonic fibroblasts, respectively (Jacobs et al., 2000; Brummelkamp et al., 2002;…”
BackgroundInfluentialTbx3 improves the germ-line competency of induced pluripotent stem cells
Han, J., Yuan, P., Yang, H., Zhang, J., Soh, B. S., Li, P., Lim, S. L., Cao, S., Tay, J., Orlov, Y. L., et al. (2010) · Nature · doi:10.1038/nature08735 · Cited by 285 · cited 2×
“More relevant to our work on the importance of the CAPERα/TBX3 complex to prevent senescence and regulate cell proliferation are reports that Tbx3 improves the pluripotency of iPS cells (Han et al., 2010) and prevents differentiation of mouse ES cells (Ivanova et al., 2006).”
BackgroundKosar, M., Bartkova, J., Hubackova, S., Hodny, Z., Lukas, J., & Bartek, J. (2011) · Cell Cycle · doi:10.4161/cc.10.3.14707 · Cited by 283
Hubackova, S., Krejcikova, K., Bartek, J., & Hodny, Z. (2012) · Aging · doi:10.18632/aging.100520 · Cited by 272 · cited 2×
“…CAPERα/TBX3 targets, as the complex roles of these pathways in the senescence associated secretory phenotype, inducing or enforcing autocrine and paracrine senescence, and tumor progression are emerging (Hubackova et al., 2010; Senturk et al., 2010; Hubackova et al., 2012; Davalos et al., 2013).”
BackgroundDowhan, D. H., Hong, E. P., Auboeuf, D., Dennis, A. P., Wilson, M. M., Berget, S. M., & O'Malley, B. W. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.12.025 · Cited by 193 · cited 1×
“CAPERα regulates hormone responsive expression and alternative splicing of minigene reporters in vitro (Jung et al., 2002; Dowhan et al., 2005) but its in vivo functions are unknown.”
BackgroundQuiescence-induced LncRNAs trigger H4K20 trimethylation and transcriptional silencing
Bierhoff, H., Dammert, M. A., Brocks, D., Dambacher, S., Schotta, G., & Grummt, I. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.03.032 · Cited by 179
The Spectrum of Mutations in TBX3: Genotype/Phenotype Relationship in Ulnar-Mammary Syndrome
Bamshad, M., Le, T., Watkins, W. S., Dixon, M. E., Kramer, B. E., Roeder, A. D., Carey, J. C., Root, S., Schinzel, A., Van Maldergem, L., et al. (1999) · The American Journal of Human Genetics · doi:10.1086/302417 · Cited by 175 · cited 3×
“We thus questioned whether the endogenous proteins interact in mouse tissues relevant to malformations seen in humans with UMS.”
BackgroundInfluentialLingbeek, M. E., Jacobs, J. J. L., & van Lohuizen, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200403200 · Cited by 160 · cited 2×
“Antibodies against TBX3 and CAPER ChIP'd the p14ARF initiator (Lingbeek et al., 2002) (Figure 3—figure supplement 4A); whereas knockdown of either TBX3 or CAPER results in marked changes in cell morphology and increased lacZ staining.”
BackgroundTbx3 Represses E-Cadherin Expression and Enhances Melanoma Invasiveness
Rodriguez, M., Aladowicz, E., Lanfrancone, L., & Goding, C. R. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0301 · Cited by 157
Brummelkamp, T. R., Kortlever, R. M., Lingbeek, M., Trettel, F., MacDonald, M. E., van Lohuizen, M., & Bernards, R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110492200 · Cited by 154 · cited 6×
“…7 of 28 Research article Previous studies have suggested that overexpression of TBX3 permits senescence bypass by directly repressing CDKN2A-p14ARF (p14ARF) to activate p53 (Brummelkamp et al., 2002), but a role for TBX3 in regulating p16INK and the RB pathway has not been demonstrated.”
BackgroundInfluentialColl, M., Seidman, J. G., & Müller, C. W. (2002) · Structure · doi:10.1016/s0969-2126(02)00722-0 · Cited by 121 · cited 1×
“TBX3 DNA binding and repressor domains (DBD, RD) independently mediate interactions with partner proteins (Carlson et al., 2001; Coll et al., 2002; Kumar et al., 2014).”
Backgroundp53 induces transcriptional and translational programs to suppress cell proliferation and growth
Loayza-Puch, F., Drost, J., Rooijers, K., Lopes, R., Elkon, R., & Agami, R. (2013) · Genome Biology · doi:10.1186/gb-2013-14-4-r32 · Cited by 114 · cited 5×
“(N ) Venn diagram showing 48 CAPER /TBX3 co-upregulated transcripts also upregulated by RAS/OIS (Loayza-Puch et al., 2013), especially in BP categories of transcriptional regulation and programmed cell (pc) death.”
BackgroundInfluentialHuR Uses AUF1 as a Cofactor To Promote p16INK4 mRNA Decay
Chang, N., Yi, J., Guo, G., Liu, X., Shang, Y., Tong, T., Cui, Q., Zhan, M., Gorospe, M., & Wang, W. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00169-10 · Cited by 112 · cited 3×
“The t1/2 of p16INK mRNA we observed in HFFs transfected with either control plasmid (t1/2–3.9) or control siRNA (t1/2–2.1) is similar to that reported in HeLa cells (t1/2–2.9) (Chang et al., 2010).”
BackgroundResultInfluentialCarlson, H. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.21.2403 · Cited by 108 · cited 5×
“TBX3 DNA binding and repressor domains (DBD, RD) independently mediate interactions with partner proteins (Carlson et al., 2001; Coll et al., 2002; Kumar et al., 2014).”
BackgroundInfluentialTBX3 Is Overexpressed in Breast Cancer and Represses p14ARF by Interacting with Histone Deacetylases
Yarosh, W., Barrientos, T., Esmailpour, T., Lin, L., Carpenter, P. M., Osann, K., Anton-Culver, H., & Huang, T. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5012 · Cited by 105
Telomerase Maintains Telomere Structure in Normal Human Cells
Masutomi, K., Yu, E. Y., Khurts, S., Ben-Porath, I., Currier, J. L., Metz, G. B., Brooks, M. W., Kaneko, S., Murakami, S., DeCaprio, J. A., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00550-6 · Cited by 70 · cited 5×
“…the pRb, p53, and p16 shRNAs was validated with second shRNAs, and these reagents have been used extensively by many investigators in the years since their initial publication (Masutomi et al., 2003; Stewart et al., 2003; Boehm et al., 2005; Haga et al., 2007; Hong et al., 2009; Elzi et al., 2012).”
BackgroundMethodInfluentialThe T-box transcription factor, TBX3, is sufficient to promote melanoma formation and invasion
Peres, J., & Prince, S. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-117 · Cited by 50
Zhu, D., Xu, G., Ghandhi, S., & Hubbard, K. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10147 · Cited by 49 · cited 2×
“, 2012) and hnRNP A1 has been postulated to stabilize p16INK mRNA (Zhu et al., 2002), but this has not been tested.”
BackgroundMouse Tbx3 Mutants Suggest Novel Molecular Mechanisms for Ulnar-Mammary Syndrome
Frank, D. U., Emechebe, U., Thomas, K. R., & Moon, A. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067841 · Cited by 39 · cited 4×
“Efforts to understand the molecular biogenesis of this developmental disorder uncovered additional functions for TBX3 beyond transcriptional repression (Fan et al., 2009; Frank et al., 2013; Kumar et al., 2014) as well as critical roles in adult tissue homeostasis (Frank et al., 2012).”
BackgroundInfluentialSelf-citation
Cited by
Mechanisms of long noncoding RNA function in development and disease
Schmitz, S. U., Grote, P., & Herrmann, B. G. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2174-5 · Cited by 1,095
Nuclear Long Noncoding RNAs: Key Regulators of Gene Expression
Sun, Q., Hao, Q., & Prasanth, K. V. (2018) · Trends in Genetics · doi:10.1016/j.tig.2017.11.005 · Cited by 565
Aging Biomarker Consortium, Bao, H., Cao, J., Chen, M., Chen, M., Chen, W., Chen, X., Chen, Y., Chen, Y., Chen, Y., et al. (2023) · Science China Life Sciences · doi:10.1007/s11427-023-2305-0 · Cited by 376
Arginine reprograms metabolism in liver cancer via RBM39
Mossmann, D., Müller, C., Park, S., Ryback, B., Colombi, M., Ritter, N., Weißenberger, D., Dazert, E., Coto-Llerena, M., Nuciforo, S., et al. (2023) · Cell · doi:10.1016/j.cell.2023.09.011 · Cited by 293
The roles and regulation of TBX3 in development and disease
Khan, S. F., Damerell, V., Omar, R., Du Toit, M., Khan, M., Maranyane, H. M., Mlaza, M., Bleloch, J., Bellis, C., Sahm, B. D. B., et al. (2020) · Gene · doi:10.1016/j.gene.2019.144223 · Cited by 99
Metadata
- Authors
- Kumar P, P., Emechebe, U., Smith, R., Franklin, S., Moore, B., Yandell, M., Lessnick, S. L., & Moon, A. M.
- Venue
- eLife
- Publisher
- eLife Sciences Publications, Ltd
- Published
- 2014-05-29
- Volume
- 3
- ISSN
- 2050-084X (ISSN-L)
- OpenAlex
- W2162547052
- Cited by
- 88
- References
- 28
- FWCI
- 6.03
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.